83 filings
8-K
TECX
Tectonic Therapeutic Inc.
20 Jun 24
Tectonic Therapeutic Announces Closing of Merger with AVROBIO as well as Concurrent Private Placement of $130.7 Million
4:25pm
8-K/A
TECX
Tectonic Therapeutic Inc.
18 Jun 24
Other Events
11:51am
8-K
TECX
Tectonic Therapeutic Inc.
14 Jun 24
Other Events
4:30pm
8-K
TECX
Tectonic Therapeutic Inc.
11 Jun 24
Submission of Matters to a Vote of Security Holders
4:29pm
8-K
TECX
Tectonic Therapeutic Inc.
4 Jun 24
Other Events
9:30am
8-K
yon5d2k2g8 pirgqq
30 Jan 24
Regulation FD Disclosure
4:05pm
8-K
rfhi1jd3e7l icr6uc2
30 Jan 24
AVROBIO and Tectonic Therapeutic Announce Merger
8:39am
8-K
uj20pl605u93jepet8
12 Jul 23
AVROBIO to Explore Strategic Alternatives
7:13am
8-K/A
7emy1d8hn71x1mhze
14 Jun 23
Cost Associated with Exit or Disposal Activities
5:19pm
8-K
s6dxb ffuoqxxk6k
13 Jun 23
Other Events
4:41pm
8-K
s0xc51k kxz
12 Jun 23
Termination of a Material Definitive Agreement
7:19am
8-K
mgfpk853l0rp qh
9 Jun 23
Departure of Directors or Certain Officers
4:11pm
8-K
0xxn4uc
22 May 23
AVROBIO Announces Agreement to Sell Cystinosis Gene Therapy Program for $87.5 Million
7:04am
8-K
xxxj8b nn9om
18 May 23
AVROBIO Announces Positive Data from Phase 1/2 Clinical Trial of
7:11am
8-K
2vu23
11 May 23
AVROBIO Reports First Quarter 2023 Financial Results and Provides Business Update
7:20am
8-K
2hesvk90vxyi
1 May 23
AVROBIO Announces Leadership Transition
7:40am
8-K
3y7k347gxqo jtl
23 Mar 23
AVROBIO Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Update
7:11am
8-K
vvnr6arkfc5avt9
27 Feb 23
Other Events
4:39pm
8-K
y0k9bapx
7 Dec 22
Regulation FD Disclosure
7:37am
8-K
yuvddu3
8 Nov 22
AVROBIO Reports Third Quarter 2022 Financial Results and Provides Business Update
7:15am